BREAKING
Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 19 hours ago Zoom Communications Q4 2025 Earnings Results 2 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 2 days ago Synopsys Q1 2026 Earnings Results 2 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 2 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 2 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 3 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 4 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 4 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 4 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 19 hours ago Zoom Communications Q4 2025 Earnings Results 2 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 2 days ago Synopsys Q1 2026 Earnings Results 2 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 2 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 2 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 3 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 4 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 4 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 4 days ago
ADVERTISEMENT
Market News

Highlights of Aurora Cannabis (ACB) Q4 2020 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease in revenues. The company’s stock fell sharply during Tuesday’s after-hours trading session soon after the announcement. The Canada-based medical marijuana company said its loss from continuing operations widened to C$1.86 billion in the fourth quarter […]

$ACB September 22, 2020 1 min read
NYSE
$ACB · Earnings

Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease in revenues. The company’s stock fell sharply during Tuesday’s after-hours trading session soon after the announcement. The Canada-based medical marijuana company said its loss from continuing operations widened to C$1.86 billion in the fourth quarter […]

· September 22, 2020

Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease in revenues. The company’s stock fell sharply during Tuesday’s after-hours trading session soon after the announcement.

The Canada-based medical marijuana company said its loss from continuing operations widened to C$1.86 billion in the fourth quarter from C$136.13 million in the third quarter. The deterioration in the bottom-line performance reflects a 5% decrease in revenues to C$72.1 million.


Looking forward to reading management/analysts’ comments on Q4 results? Stay tuned here for Aurora’s Q4 2020 earnings call transcript 


Shares of Aurora Cannabis closed Tuesday’s regular session higher in the New York Stock Exchange but decreased during the extended trading session. The stock, which has been on a losing streak for several months, has lost about 70% so far this year.

ADVERTISEMENT